193 related articles for article (PubMed ID: 38118413)
1. PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition.
Li Y; Dobrolecki LE; Sallas C; Zhang X; Kerr TD; Bisht D; Wang Y; Awasthi S; Kaundal B; Wu S; Peng W; Mendillo ML; Lu Y; Jeter CR; Peng G; Liu J; Westin SN; Sood AK; Lewis MT; Das J; Yi SS; Bedford MT; McGrail DJ; Sahni N
Cell Rep Med; 2023 Dec; 4(12):101326. PubMed ID: 38118413
[TBL] [Abstract][Full Text] [Related]
2. Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance.
Zhu Y; Xia T; Chen DQ; Xiong X; Shi L; Zuo Y; Xiao H; Liu L
Drug Resist Updat; 2024 Jan; 72():101016. PubMed ID: 37980859
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting PRMT5 induces DNA damage and increases anti-proliferative activity of Niraparib, a PARP inhibitor, in models of breast and ovarian cancer.
O'Brien S; Butticello M; Thompson C; Wilson B; Wyce A; Mahajan V; Kruger R; Mohammad H; Fedoriw A
BMC Cancer; 2023 Aug; 23(1):775. PubMed ID: 37596538
[TBL] [Abstract][Full Text] [Related]
4. PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies.
Carter J; Hulse M; Sivakumar M; Burtell J; Thodima V; Wang M; Agarwal A; Vykuntam K; Spruance J; Bhagwat N; Rager J; Ruggeri B; Scherle P; Ito K
Cancer Res Commun; 2023 Nov; 3(11):2233-2243. PubMed ID: 37861290
[TBL] [Abstract][Full Text] [Related]
5. Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation.
Maron MI; Casill AD; Gupta V; Roth JS; Sidoli S; Query CC; Gamble MJ; Shechter D
Elife; 2022 Jan; 11():. PubMed ID: 34984976
[TBL] [Abstract][Full Text] [Related]
6. The macromolecular complexes of histones affect protein arginine methyltransferase activities.
Fulton MD; Cao M; Ho MC; Zhao X; Zheng YG
J Biol Chem; 2021 Oct; 297(4):101123. PubMed ID: 34492270
[TBL] [Abstract][Full Text] [Related]
7. Functional Study of
Lorenzon L; Quilles JC; Campagnaro GD; Azevedo Orsine L; Almeida L; Veras F; Miserani Magalhães RD; Alcoforado Diniz J; Rodrigues Ferreira T; Kaysel Cruz A
ACS Infect Dis; 2022 Mar; 8(3):516-532. PubMed ID: 35226477
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of type I PRMT and PARP inhibitors against non-small cell lung cancer cells.
Dominici C; Sgarioto N; Yu Z; Sesma-Sanz L; Masson JY; Richard S; Raynal NJ
Clin Epigenetics; 2021 Mar; 13(1):54. PubMed ID: 33691794
[TBL] [Abstract][Full Text] [Related]
9. An updated patent review of protein arginine N-methyltransferase inhibitors (2019-2022).
Dong J; Duan J; Hui Z; Garrido C; Deng Z; Xie T; Ye XY
Expert Opin Ther Pat; 2022 Dec; 32(12):1185-1205. PubMed ID: 36594709
[TBL] [Abstract][Full Text] [Related]
10. Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth.
Li WJ; He YH; Yang JJ; Hu GS; Lin YA; Ran T; Peng BL; Xie BL; Huang MF; Gao X; Huang HH; Zhu HH; Ye F; Liu W
Nat Commun; 2021 Mar; 12(1):1946. PubMed ID: 33782401
[TBL] [Abstract][Full Text] [Related]
11. Structural and biochemical evaluation of bisubstrate inhibitors of protein arginine N-methyltransferases PRMT1 and CARM1 (PRMT4).
Gunnell EA; Al-Noori A; Muhsen U; Davies CC; Dowden J; Dreveny I
Biochem J; 2020 Feb; 477(4):787-800. PubMed ID: 32011657
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous ablation of prmt-1 and prmt-5 abolishes asymmetric and symmetric arginine dimethylations in Caenorhabditis elegans.
Hirota K; Shigekawa C; Araoi S; Sha L; Inagawa T; Kanou A; Kako K; Daitoku H; Fukamizu A
J Biochem; 2017 Jun; 161(6):521-527. PubMed ID: 28158808
[TBL] [Abstract][Full Text] [Related]
13. A patent review of arginine methyltransferase inhibitors (2010-2018).
Li X; Wang C; Jiang H; Luo C
Expert Opin Ther Pat; 2019 Feb; 29(2):97-114. PubMed ID: 30640571
[TBL] [Abstract][Full Text] [Related]
14. Transient Kinetics Define a Complete Kinetic Model for Protein Arginine Methyltransferase 1.
Hu H; Luo C; Zheng YG
J Biol Chem; 2016 Dec; 291(52):26722-26738. PubMed ID: 27834681
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss.
Fedoriw A; Rajapurkar SR; O'Brien S; Gerhart SV; Mitchell LH; Adams ND; Rioux N; Lingaraj T; Ribich SA; Pappalardi MB; Shah N; Laraio J; Liu Y; Butticello M; Carpenter CL; Creasy C; Korenchuk S; McCabe MT; McHugh CF; Nagarajan R; Wagner C; Zappacosta F; Annan R; Concha NO; Thomas RA; Hart TK; Smith JJ; Copeland RA; Moyer MP; Campbell J; Stickland K; Mills J; Jacques-O'Hagan S; Allain C; Johnston D; Raimondi A; Porter Scott M; Waters N; Swinger K; Boriack-Sjodin A; Riera T; Shapiro G; Chesworth R; Prinjha RK; Kruger RG; Barbash O; Mohammad HP
Cancer Cell; 2019 Jul; 36(1):100-114.e25. PubMed ID: 31257072
[TBL] [Abstract][Full Text] [Related]
16. Protein arginine methyltransferase biology in humans during acute and chronic skeletal muscle plasticity.
vanLieshout TL; Bonafiglia JT; Gurd BJ; Ljubicic V
J Appl Physiol (1985); 2019 Sep; 127(3):867-880. PubMed ID: 31369333
[TBL] [Abstract][Full Text] [Related]
17. Protein arginine methyltransferase expression, localization, and activity during disuse-induced skeletal muscle plasticity.
Stouth DW; Manta A; Ljubicic V
Am J Physiol Cell Physiol; 2018 Feb; 314(2):C177-C190. PubMed ID: 29092819
[TBL] [Abstract][Full Text] [Related]
18. The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLAR
Li M; An W; Xu L; Lin Y; Su L; Liu X
J Exp Clin Cancer Res; 2019 Feb; 38(1):64. PubMed ID: 30736843
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation.
Fong JY; Pignata L; Goy PA; Kawabata KC; Lee SC; Koh CM; Musiani D; Massignani E; Kotini AG; Penson A; Wun CM; Shen Y; Schwarz M; Low DH; Rialdi A; Ki M; Wollmann H; Mzoughi S; Gay F; Thompson C; Hart T; Barbash O; Luciani GM; Szewczyk MM; Wouters BJ; Delwel R; Papapetrou EP; Barsyte-Lovejoy D; Arrowsmith CH; Minden MD; Jin J; Melnick A; Bonaldi T; Abdel-Wahab O; Guccione E
Cancer Cell; 2019 Aug; 36(2):194-209.e9. PubMed ID: 31408619
[TBL] [Abstract][Full Text] [Related]
20. A peptoid-based inhibitor of protein arginine methyltransferase 1 (PRMT1) induces apoptosis and autophagy in cancer cells.
Brekker MA; Sartawi T; Sawatzky TM; Causey CP; Rehman FK; Knuckley B
J Biol Chem; 2022 Aug; 298(8):102205. PubMed ID: 35764172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
